Deep venous thrombosis (DVT) during pregnancy is associated with high mortality,
morbidity, and costs. Pulmonary embolism (PE), its most feared complication, is the leading …

This article discusses the management of venous thromboembolism (VTE) and
thrombophilia, as well as the use of antithrombotic agents, during pregnancy and is part of …

Background Prior thrombosis is a well-established risk factor for re-thrombosis in
polycythemia vera and essential thrombocythemia but scarce data are available on the rate …

Inherited thrombophilia, defined as a genetically determined tendency to develop venous
thromboembolism (VTE), contributes to the pathogenesis of~ 40% of VTE episodes. About …

Much emphasis has been placed on the impact factor, a measure of journal article citation
rates used as a surrogate marker of both journal and article quality. There is little doubt that …

Non‐rare thrombophilia (NRT) are hereditary predispositions to thromboembolism, the most
severe side effect of combined hormonal contraception. In the mid‐1990s, the identification …

Pregnancy is associated with an increased risk of venous thromboembolism (VTE), and this
condition remains an important cause of maternal morbidity and mortality. Approximately …

INTRODUCTION: Management of pregnant women at risk for venous thromboembolism
(VTE) remains complex. Guidelines do not definitively fix optimal strategies due to limited …

It is uncertain whether the presence of inherited thrombophilia influences the risk of
developing symptomatic pulmonary embolism (PE) and whether different thrombophilic …

We retrospectively analyzed 542 proven/probable mould infections registered, in the course
of 2 studies, in 8,633 patients with acute leukemia, focusing on scedosporiosis. We aimed to …